Skip to content

Comparative mobilization and traction techniques for cervicogenic Headache:

The effectiveness of C1-C2 Sustained Natural Apophyseal Glide mobilization and Mulligan traction in comparison with Maitland mobilization and traction on cervicogenic headache

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251118068034N1
Enrollment
54
Registered
2025-12-22
Start date
2025-12-11
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervicogenic headache. Cervicogenic headache

Interventions

Intervention 1: Mulligan Intervention group: In the Mulligan intervention group, the patient is seated on a chair with their back supported by the chair’s backrest. The head and neck are kept in a neu

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Unilateral headache or headache predominantly on one side without side shifting Headache accompanied by neck stiffness and pain, which increases with neck movement Cervical spine dysfunction Restricted cervical range of motion and a limitation of more than 10 degrees in the Flexion-Rotation Test Headache episodes occurring at least once per week during the past three months Age between 18 and 60 years Participants must have the ability to understand and read Persian to complete the questionnaires

Exclusion criteria

Exclusion criteria: Headache originating from sources other than the cervical spine Patient with cervical disc herniation Any fracture or history of surgery in the cervical region Patient has received any physiotherapy or chiropractic treatment in the past 3 months Any history of severe osteoporosis, bone tumor, rheumatoid arthritis, or ankylosing spondylosis History of pain-reducing injections Instability of the upper cervical vertebrae Cervical artery insufficiency Pregnancy Any contraindication to manual therapy Presence of vascular disorders, such as cervical carotid artery disease Absence from two or more consecutive treatment sessions

Design outcomes

Primary

MeasureTime frame
Mean Pain Intensity: In this study, pain refers to the discomfort experienced by the patient as a result of this condition. Pain intensity is measured using the Numeric Pain Rating Scale (NPRS), ranging from 0 (no pain) to 10 (the highest possible pain), and is recorded by the participant in the headache questionnaire. Timepoint: Pain intensity is measured before the start of the study, at the final treatment session, and also at the three-month follow-up. Method of measurement: In this study, pain intensity is assessed using the Numeric Pain Rating Scale (NPRS). Participants rate their pain at each time point on a scale from 0 to 10, where 0 represents “no pain” and 10 represents “the worst possible pain.” This scale is completed by the participants themselves in the headache questionnaire and serves as the primary measure of pain intensity throughout the study.;Mean frequency of headache: The mean frequency of headache in this study is determined based on the data recorded in the daily diary. Participants are required to mark the days of each month on which they experience a headache. The number of marked days per month is then extracted, and the mean of these monthly values over the course of the study is calculated and reported as the mean headache frequency. Timepoint: The headache frequency in this study is measured before the start of the study, at the final treatment session, and also at the three-month follow-up.”. Method of measurement: In this study, the mean headache frequency is determined based on a daily diary. Participants are required to mark the days of each month on which they experience a headache. The number of marked days per month is then extracted, and the mean of these values over the course of the study is calculated and recorded as the mean headache frequency.

Secondary

MeasureTime frame
Mean duration of headache in the past month: The mean duration of headache attacks in the past month represents the average length of each headache attack over the last 30 days, typically calculated using a daily headache diary. Timepoint: The duration of headaches in this study is measured before the start of the study, at the final treatment session, and also at the three-month follow-up. Method of measurement: The duration of headache attacks is measured using a daily headache diary, in which patients record the start and end time of each attack. The duration of each attack is then calculated, and the mean duration over the study period (e.g., one month) is determined. This method allows for accurate assessment of changes in headache duration and patterns before and after therapeutic interventions.;Mean flexion-rotation range: The Flexion-Rotation Test (FRT) is a specific test for assessing the function of the atlantoaxial joint (C1-C2) and is commonly used in patients with cervicogenic headaches. Timepoint: The mean flexion-rotation range in this study is measured before the start of the study, at the final treatment session, and at the three-month follow-up. Method of measurement: In this test, the patient lies supine on a table with the shoulders positioned at the end, while the therapist supports the head using their abdomen. The patient’s neck is gently brought into full flexion to lock the lower cervical segments, focusing movement primarily at the C1-C2 level. The head is then slowly rotated to the right and left while maintaining this flexed position, and the range of rotation in each direction is measured using a goniometer. This method allows precise evaluation of C1-C2 movement limitations and patterns, serving as a specific measure of upper cervical spine function.;Functional disability resulting from headache: The term "disability" refers to a set of limitations and impairments—physical, cognitive, or emotional—caused by a disease or injury, as well

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaezeh Sedghi

Iran University of Medical Sciences

Faezehsedghi2000@gmail.com+98 21 2225 6434

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026